COMMUNIQUÉS West-GlobeNewswire

AI. Robotics. Automation. DLH Technology and Innovation Powers Recently Honored Projects
17/06/2025
ATLANTA, June 17, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital [...]
Labviva Announces Key Executive Appointments to Drive Global Expansion
17/06/2025
Company scales leadership to accelerate growth and reinforce market position as the leader in AI-powered life sciences procurement BOSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Labviva , the leading AI procurement platform [...]
Adial Pharmaceuticals Announces Pricing of $3.6 Million Public Offering
17/06/2025
GLEN ALLEN, Va., June 17, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]
Saudi Arabia Introduces Strategic Healthcare Vision and Global Partnerships at BIO 2025
17/06/2025
BOSTON, June 17, 2025 (GLOBE NEWSWIRE) -- Saudi Arabia officially opened its national pavilion today at the BIO International Convention 2025, marking a milestone moment in its journey to become a global biotechnology [...]
Aptose Provides Corporate Updates
17/06/2025
Announces short-term cash advance SAN DIEGO and TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“ Aptose ” or the “ Company ”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company, [...]
Press release: Sanofi successfully prices €1.5 billion bond issue
17/06/2025
Sanofi successfully prices €1.5 billion bond issue Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million fixed-rate notes, due June [...]
Communiqué de presse : Sanofi place 1,5 milliard d’euros d’emprunts obligataires
17/06/2025
Sanofi place 1,5 milliard d’euros d’emprunts obligataires Paris, 17 juin 2025 - Sanofi annonce avoir placé avec succès une émission obligataire en 2 tranches (les « obligations ») pour un montant de 1,5 milliard d’euros [...]
Endogenex to Present Data on Endoscopic Procedure for Type 2 Diabetes at American Diabetes Association’s (ADA) 85th Scientific Sessions
17/06/2025
MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), will present results from its REGENT-1 [...]
Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
17/06/2025
- Broad Use of Suprachoroidal Injection Platform Highlighted Across Retinal Indications - - CLS-AX Combines the Flexibility of Anti-VEGF Therapies with the Long-Lasting Benefits of a Tyrosine Kinase Inhibitor - [...]
Lifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing Customer
17/06/2025
Represents Continuation of Long-Running Partnership Focused on Supporting Advancement of Novel Ophthalmic Therapeutic Toward Commercialization CHASKA, Minn., June 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. ( [...]
Eccogene to Report Preclinical Data with ECC4703, Showcasing Impact on Lean Muscle Sparing and Fat Loss in Combination with Semaglutide and Tirzepatide
17/06/2025
Late-breaking poster presentation to be reviewed at the upcoming American Diabetes Association’s 85th Scientific Sessions BOSTON and SHANGHAI, June 17, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage [...]
Counslr Partners with Hacking HR to Provide 24/7 Mental Health Support for Members
17/06/2025
Supporting Professionals Who Are Shaping the Future of Work NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Hacking HR, the fastest growing global community of HR leaders and practitioners, announced its partnership with [...]
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East
17/06/2025
REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious [...]
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
17/06/2025
Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3 trial for NDV-01 expected to begin in H1 2026 CORAL GABLES, Fla., June 17, 2025 (GLOBE [...]
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
17/06/2025
The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF and plasma exposures reinforce VTX3232’s potential as a once-daily oral therapy for [...]
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
17/06/2025
SAN DIEGO, June 17, 2025 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health [...]
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
17/06/2025
- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial [...]
Vireo Growth Inc. Provides Corporate Update Post Closing of All Merger Transactions
17/06/2025
MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today announced a series of corporate updates following the closing of all its previously-announced [...]
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
17/06/2025
New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally Exhibiting at European [...]

Pages